← 產業報告目錄

Negative Pressure Wound Therapy Market by Product (Conventional, Single-use NPWT, Consumables, Accessories), Wound Type (Burns, Surgical, Traumatic, Diabetic Foot, Pressure, Venous Leg Ulcers), End User (Hospitals, Homecare) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-05-26頁數 249報告編號 MD6656

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global negative pressure wound therapy market is projected to reach USD 3.84 billion by 2030 from USD 2.76 billion in 2025, at a CAGR of 6.9% during the forecast period. This is due to the increasing rise of diabetic patients, rising cases of traumatic injuries and burn injuries, and the growing geriatric population, which drives market growth. Additionally, rising usage of simplified single-use devices is expected to impact market growth. “The hospitals segment of the negative pressure wound therapy market, by end user, is expected to hold the largest position during the forecast period.” Based on the end user, the negative pressure wound therapy market is divided into home care settings, hospitals, and other end users. Among these, hospitals hold the largest market share in 2024. The need for advanced wound care products in hospitals has been further stimulated by the rising incidence of diabetic foot ulcers and post-operative wounds. Hospital visits for wound care have also increased as a result of the growing geriatric population with chronic illnesses, including diabetes and vascular diseases. Hospitals can treat wounds quickly and effectively due to established protocols, knowledgeable medical staff, and a wide range of traditional wound care materials. As a result of the increased focus on improving wound care practices and patient recovery rates, this market segment continues to hold its dominant position. “The burns and surgical & open wounds accounted for the largest market share in the negative pressure wound therapy market.” The negative pressure wound therapy market is segmented into burns and surgical & open wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and traumatic wounds. The burns and surgical & open wounds segment accounted for the largest share in the negative pressure wound therapy market in 2024. Burns and surgical & open wounds are leading segments in the negative pressure wound therapy market due to their rising occurrence and complexity, which require advanced wound management solutions. NPWT devices are particularly effective in managing these types of wounds, as they promote quicker healing, reduce infection risk, and improve tissue regeneration. Surgical wounds involving large incisions or at risk of dehiscence benefit significantly from maintaining a clean, moist wound environment and reducing edema. “Asia Pacific is the fastest-growing region of the negative pressure wound therapy market by region.” The global negative pressure wound therapy market is segmented into five segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific negative pressure wound therapy market is growing due to the geriatric population, rising healthcare costs, and a growing incidence of chronic wounds. Asia Pacific offers high growth opportunities for players in the market. This segment is slated to register the highest CAGR during the forecast period. As the number of surgeries, road accidents, and burn cases increases, there is an increasing need for effective wound care therapies. The growing incidence of diabetes has led to a rise in diabetic foot ulcers, highlighting the significance of proper wound care. The expansion of the healthcare system, e-commerce, and pharmacies has made the negative pressure wound therapy product accessible than ever. As awareness of wound care improves and healthcare services advance, the demand for negative pressure wound therapy solutions in the Mexico region is expected to see continued growth. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1: 38%, Tier 2: 29%, and Tier 3: 33% • By Designation: C Level: 27%, Director Level: 18%, and Others: 55% • By Region: North America: 50%, Europe: 20%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 3% Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion. Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs. Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers. The major players operating in the negative pressure wound therapy market are Solventum (US), Smith+Nephew (UK), Cardinal Health (US), Mölnlycke AB (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Avery Dennison Corporation (US), BenQ Materials Corporation (Taiwan), Double Medical Technology Inc. (China), Advanced Oxygen Therapy Inc. (US), and Carilex Medical (Taiwan). Research Coverage This report studies the negative pressure wound therapy market based on product type, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions). Reasons to Buy the Report The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence. This report provides insights on the following pointers:  Analysis of key drivers (booming geriatric population, increasing cases of traumatic injuries, growing prevalence of chronic diseases rising incidence of burn injuries and favorable government and industry initiatives and reimbursements), restraints (high cost of negative pressure wound devices, and risks associated with use of negative pressure wound therapy products), opportunities (high growth opportunities in emerging economies and growing usage of simplified single-use devices), challenges (availability of alternative therapies, and Limited awareness among healthcare providers)  Market Penetration: Comprehensive information on the product portfolios offered by the top players in the negative pressure wound therapy market  Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the negative pressure wound therapy market  Market Development: Comprehensive information on lucrative emerging regions  Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the negative pressure wound therapy market  Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
目錄 Table of Contents
1 INTRODUCTION 26 1.1 STUDY OBJECTIVES 26 1.2 MARKET DEFINITION 26 1.3 STUDY SCOPE 27 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 27 1.3.2 INCLUSIONS AND EXCLUSIONS 28 1.3.3 YEARS CONSIDERED 28 1.4 CURRENCY CONSIDERED 29 1.5 STAKEHOLDERS 29 1.6 SUMMARY OF CHANGES 29 2 RESEARCH METHODOLOGY 31 2.1 RESEARCH DATA 31 2.1.1 SECONDARY DATA 31 2.1.1.1 Key data from secondary sources 32 2.1.2 PRIMARY DATA 33 2.1.2.1 Primary sources 33 2.1.2.2 Key industry insights 34 2.1.2.3 Key data from primary sources 34 2.1.2.4 Breakdown of primary interviews 35 2.2 MARKET SIZE ESTIMATION 35 2.2.1 BOTTOM-UP APPROACH 36 2.2.1.1 Approach 1: Company revenue estimation approach 36 2.2.1.2 Approach 2: Presentations of companies and primary interviews 36 2.2.1.3 Approach 3: Primary interviews 36 2.2.1.4 Growth forecast 37 2.2.1.5 CAGR projections 37 2.2.2 TOP-DOWN APPROACH 38 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 39 2.4 RESEARCH ASSUMPTIONS 40 2.4.1 STUDY-RELATED ASSUMPTIONS 40 2.4.2 PARAMETRIC ASSUMPTIONS 40 2.4.3 GROWTH RATE ASSUMPTIONS 40 2.5 RESEARCH LIMITATIONS 41 2.6 RISK ASSESSMENT 41 3 EXECUTIVE SUMMARY 42   4 PREMIUM INSIGHTS 46 4.1 NEGATIVE PRESSURE WOUND THERAPY MARKET OVERVIEW 46 4.2 ASIA PACIFIC NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER AND COUNTRY 47 4.3 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY KEY COUNTRY 48 4.4 NEGATIVE PRESSURE WOUND THERAPY MARKET, REGIONAL MIX, 2025 VS. 2030 48 5 MARKET OVERVIEW 49 5.1 INTRODUCTION 49 5.2 MARKET DYNAMICS 49 5.2.1 DRIVERS 50 5.2.1.1 Booming geriatric population 50 5.2.1.2 Increasing cases of traumatic injuries 50 5.2.1.3 Growing prevalence of chronic diseases 51 5.2.1.4 Rising incidence of burn injuries 52 5.2.1.5 Favorable government and industry initiatives and reimbursement policies 53 5.2.2 RESTRAINTS 54 5.2.2.1 High cost of negative pressure wound therapy devices 54 5.2.2.2 Risks associated with use of negative pressure wound therapy products 54 5.2.3 OPPORTUNITIES 55 5.2.3.1 Growth opportunities in emerging economies 55 5.2.3.2 Increasing use of simplified single-use devices 56 5.2.4 CHALLENGES 56 5.2.4.1 Availability of alternative therapies 56 5.2.4.2 Limited awareness among healthcare providers 56 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 57 5.4 PRICING ANALYSIS 57 5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 58 5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 58 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 59 5.5 VALUE CHAIN ANALYSIS 59 5.6 SUPPLY CHAIN ANALYSIS 61 5.7 ECOSYSTEM ANALYSIS 62 5.8 INVESTMENT AND FUNDING SCENARIO 63 5.9 TECHNOLOGY ANALYSIS 64 5.9.1 KEY TECHNOLOGIES 64 5.9.1.1 Vacuum-assisted Closure (VAC) Therapy 64 5.9.2 COMPLEMENTARY TECHNOLOGIES 64 5.9.2.1 Topical Oxygen Therapy 64   5.9.3 ADJACENT TECHNOLOGIES 65 5.9.3.1 Hyperbaric Oxygen Therapy 65 5.10 PATENT ANALYSIS 65 5.11 TRADE ANALYSIS 67 5.11.1 IMPORT DATA (HS CODE 901890) 67 5.11.2 EXPORT DATA (HS CODE 901890) 67 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 68 5.13 CASE STUDY ANALYSIS 69 5.13.1 CASE STUDY 1: COMPLEX WOUND HEALING WITH TOPICAL NEGATIVE PRESSURE WOUND THERAPY 69 5.13.2 CASE STUDY 2: NECROTIZING FASCIITIS MANAGED WITH NEGATIVE PRESSURE WOUND THERAPY FOR BETTER WOUND CLOSURE 70 5.13.3 CASE STUDY 3: TREATMENT OF HARD-TO-HEAL WOUNDS WITH PORTABLE NEGATIVE PRESSURE WOUND THERAPY 70 5.14 REGULATORY LANDSCAPE 71 5.14.1 REGULATORY ANALYSIS 71 5.14.1.1 North America 71 5.14.1.1.1 US 71 5.14.1.1.2 Canada 71 5.14.1.2 Europe 71 5.14.1.2.1 Germany 72 5.14.1.2.2 UK 72 5.14.1.2.3 France 72 5.14.1.3 Asia Pacific 72 5.14.1.3.1 China 72 5.14.1.3.2 Japan 73 5.14.1.3.3 India 73 5.14.1.4 Latin America 73 5.14.1.5 Middle East 74 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 5.14.2.1 North America 74 5.14.2.2 Europe 75 5.14.2.3 Asia Pacific 75 5.14.2.4 Latin America 76 5.14.2.5 Rest of the World 76 5.15 PORTER’S FIVE FORCES ANALYSIS 77 5.15.1 BARGAINING POWER OF SUPPLIERS 78 5.15.2 BARGAINING POWER OF BUYERS 78 5.15.3 THREAT OF NEW ENTRANTS 78 5.15.4 THREAT OF SUBSTITUTES 78 5.15.5 INTENSITY OF COMPETITIVE RIVALRY 78   5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 79 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 79 5.16.2 BUYING CRITERIA 80 5.17 IMPACT OF AI ON NEGATIVE PRESSURE WOUND THERAPY MARKET 80 5.17.1 INTRODUCTION 80 5.17.2 MARKET POTENTIAL OF AI IN NEGATIVE PRESSURE WOUND THERAPY MARKET 81 5.17.3 AI USE CASES 81 5.17.4 KEY COMPANIES IMPLEMENTING AI 82 5.17.5 FUTURE OF AI IN NEGATIVE PRESSURE WOUND THERAPY MARKET 82 5.18 IMPACT OF US TARIFF REGULATION ON NEGATIVE PRESSURE WOUND THERAPY MARKET 82 5.18.1 INTRODUCTION 82 5.18.2 KEY TARIFF RATES 83 5.18.3 PRICE IMPACT ANALYSIS 83 5.18.4 KEY IMPACT ON COUNTRY/REGION 84 5.18.4.1 North America 84 5.18.4.2 Europe 84 5.18.4.3 Asia Pacific 84 5.18.5 IMPACT ON END-USE INDUSTRIES 84 5.18.5.1 Hospitals 85 6 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE 86 6.1 INTRODUCTION 87 6.2 CONVENTIONAL NPWT DEVICES 87 6.2.1 RISING FOCUS ON EFFECTIVE WOUND MANAGEMENT TO EXPEDITE GROWTH 87 6.3 SINGLE-USE NPWT DEVICES 90 6.3.1 INCREASING ADOPTION OF SINGLE-USE DEVICES IN HOME HEALTHCARE TO PROMOTE GROWTH 90 6.4 NPWT ACCESSORIES & CONSUMABLES 93 6.4.1 GROWING PREVALENCE OF CHRONIC WOUNDS TO DRIVE MARKET 93 7 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE 97 7.1 INTRODUCTION 98 7.2 BURNS AND SURGICAL & OPEN WOUNDS 98 7.2.1 HIGH INCIDENCE OF BURN INJURIES IN LOW AND MIDDLE-INCOME COUNTRIES TO AID GROWTH 98 7.3 PRESSURE ULCERS 101 7.3.1 INCREASING AGING POPULATION WORLDWIDE TO AUGMENT GROWTH 101 7.4 DIABETIC FOOT ULCERS 104 7.4.1 INCREASE PREVALENCE OF DIABETES TO STIMULATE GROWTH 104 7.5 VENOUS LEG ULCERS 107 7.5.1 RISING PREVALENCE OF OBESITY TO CONTRIBUTE TO GROWTH 107   7.6 TRAUMATIC WOUNDS 110 7.6.1 GROWING INCIDENCE OF TRAUMATIC INJURIES TO BOOST MARKET 110 8 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER 114 8.1 INTRODUCTION 115 8.2 HOSPITALS 115 8.2.1 RISING NUMBER OF SURGERIES TO ACCELERATE GROWTH 115 8.3 HOME CARE SETTINGS 118 8.3.1 INCREASING HEALTHCARE EXPENDITURE TO SPEED UP GROWTH 118 8.4 OTHER END USERS 121 9 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY REGION 124 9.1 INTRODUCTION 125 9.2 NORTH AMERICA 125 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 126 9.2.2 US 129 9.2.2.1 Rising regulatory approvals and favorable reimbursement policies to stimulate growth 129 9.2.3 CANADA 131 9.2.3.1 Increasing prevalence of diabetes to support growth 131 9.3 EUROPE 133 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 134 9.3.2 UK 136 9.3.2.1 Increase in research & development activities to aid growth 136 9.3.3 GERMANY 138 9.3.3.1 Growing prevalence of hospital-acquired infections to propel market 138 9.3.4 FRANCE 140 9.3.4.1 Rise in healthcare budget to spur growth 140 9.3.5 ITALY 141 9.3.5.1 Increasing national healthcare funding to favor growth 141 9.3.6 SPAIN 143 9.3.6.1 Increasing number of surgical procedures to promote growth 143 9.3.7 RUSSIA 145 9.3.7.1 Escalating diabetes issue to drive market 145 9.3.8 REST OF EUROPE 146 9.4 ASIA PACIFIC 148 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 149 9.4.2 CHINA 152 9.4.2.1 Increasing incidence of diabetic foot ulcers to encourage growth 152 9.4.3 JAPAN 154 9.4.3.1 Evolving healthcare delivery and infrastructure landscape to fuel market 154   9.4.4 INDIA 156 9.4.4.1 Booming medical tourism to speed up growth 156 9.4.5 AUSTRALIA 158 9.4.5.1 Growing focus on diabetes management to drive market 158 9.4.6 SOUTH KOREA 159 9.4.6.1 Increasing awareness and focus on advanced wound care therapies to facilitate growth 159 9.4.7 SINGAPORE 161 9.4.7.1 Increasing healthcare spending to sustain growth 161 9.4.8 REST OF ASIA PACIFIC 162 9.5 LATIN AMERICA 164 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 164 9.5.2 BRAZIL 166 9.5.2.1 Free healthcare services to bolster growth 166 9.5.3 MEXICO 168 9.5.3.1 Expanding hospital infrastructure to aid growth 168 9.5.4 REST OF LATIN AMERICA 169 9.6 MIDDLE EAST & AFRICA 171 9.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET 171 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 171 10 COMPETITIVE LANDSCAPE 173 10.1 OVERVIEW 173 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024 173 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN NEGATIVE PRESSURE WOUND THERAPY MARKET 174 10.3 REVENUE ANALYSIS, 2022–2024 175 10.4 MARKET SHARE ANALYSIS, 2024 176 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 178 10.5.1 STARS 178 10.5.2 EMERGING LEADERS 178 10.5.3 PERVASIVE PLAYERS 179 10.5.4 PARTICIPANTS 179 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 180 10.5.5.1 Company footprint 180 10.5.5.2 Region footprint 181 10.5.5.3 Product type footprint 182 10.5.5.4 Wound type footprint 183 10.5.5.5 End-user footprint 184 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 184 10.6.1 PROGRESSIVE COMPANIES 184 10.6.2 RESPONSIVE COMPANIES 184 10.6.3 DYNAMIC COMPANIES 185 10.6.4 STARTING BLOCKS 185 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 186 10.6.5.1 Detailed list of key startups/SMEs 186 10.6.5.2 Competitive benchmarking of key startups/SMEs 187 10.7 COMPANY VALUATION AND FINANCIAL METRICS 188 10.7.1 COMPANY VALUATION 188 10.7.2 FINANCIAL METRICS 188 10.8 BRAND/PRODUCT COMPARISON 189 10.9 COMPETITIVE SCENARIO 190 10.9.1 PRODUCT LAUNCHES AND APPROVALS 190 10.9.2 DEALS 190 10.9.3 EXPANSIONS 192 10.9.4 OTHER DEVELOPMENTS 193 11 COMPANY PROFILES 194 11.1 KEY PLAYERS 194 11.1.1 SOLVENTUM 194 11.1.1.1 Business overview 194 11.1.1.2 Products offered 195 11.1.1.3 Recent developments 196 11.1.1.3.1 Product launches and approvals 196 11.1.1.3.2 Other developments 196 11.1.1.4 MnM view 197 11.1.1.4.1 Key strengths 197 11.1.1.4.2 Strategic choices 197 11.1.1.4.3 Weaknesses and competitive threats 197 11.1.2 SMITH+NEPHEW 198 11.1.2.1 Business overview 198 11.1.2.2 Products offered 199 11.1.2.3 Recent developments 200 11.1.2.3.1 Product launches and approvals 200 11.1.2.3.2 Deals 200 11.1.2.3.3 Expansions 201 11.1.2.4 MnM view 201 11.1.2.4.1 Key strengths 201 11.1.2.4.2 Strategic choices 201 11.1.2.4.3 Weaknesses and competitive threats 202 11.1.3 CARDINAL HEALTH 203 11.1.3.1 Business overview 203 11.1.3.2 Products offered 204 11.1.3.3 Recent developments 205 11.1.3.3.1 Deals 205 11.1.3.3.2 Expansions 206 11.1.3.4 MnM view 207 11.1.3.4.1 Key strengths 207 11.1.3.4.2 Strategic choices 207 11.1.3.4.3 Weaknesses and competitive threats 207 11.1.4 MÖLNLYCKE AB 208 11.1.4.1 Business overview 208 11.1.4.2 Products offered 209 11.1.4.3 Recent developments 210 11.1.4.3.1 Deals 210 11.1.4.4 MnM view 211 11.1.4.4.1 Key strengths 211 11.1.4.4.2 Strategic choices 211 11.1.4.4.3 Weaknesses and competitive threats 211 11.1.5 CONVATEC GROUP PLC 212 11.1.5.1 Business overview 212 11.1.5.2 Products offered 213 11.1.5.3 Recent developments 214 11.1.5.3.1 Deals 214 11.1.5.4 MnM view 214 11.1.5.4.1 Key strengths 214 11.1.5.4.2 Strategic choices 214 11.1.5.4.3 Weaknesses and competitive threats 214 11.1.6 PAUL HARTMANN AG 215 11.1.6.1 Business overview 215 11.1.6.2 Products offered 216 11.1.6.3 Recent developments 217 11.1.6.3.1 Deals 217 11.1.7 AVERY DENNISON CORPORATION 218 11.1.7.1 Business overview 218 11.1.7.2 Products offered 219 11.1.7.3 Recent developments 220 11.1.7.3.1 Deals 220 11.1.7.3.2 Expansions 220 11.1.8 BENQ MATERIALS CORPORATION 221 11.1.8.1 Business overview 221 11.1.8.2 Products offered 222 11.1.8.3 Recent developments 223 11.1.8.3.1 Deals 223 11.1.8.3.2 Other developments 223   11.1.9 ADVANCED OXYGEN THERAPY INC. 224 11.1.9.1 Business overview 224 11.1.9.2 Products offered 225 11.1.9.3 Recent developments 225 11.1.9.3.1 Product launches and approvals 225 11.2 OTHER PLAYERS 226 11.2.1 DOUBLE MEDICAL TECHNOLOGY INC. 226 11.2.2 CARILEX MEDICAL 227 11.2.3 DEROYAL INDUSTRIES, INC. 228 11.2.4 LOHMANN & RAUSCHER GMBH & CO. KG 229 11.2.5 MEDAXIS LLC 230 11.2.6 GENADYNE BIOTECHNOLOGIES, INC. 231 11.2.7 DIRECT HEALTHCARE GROUP 232 11.2.8 ALLEVA MEDICAL 233 11.2.9 CORK MEDICAL, LLC 234 11.2.10 PENSAR MEDICAL 235 11.2.11 HAROMED 236 11.2.12 GUANGZHOU RAINHOME PHARM & TECH CO., LTD. 237 11.2.13 GUARD MEDICAL 238 11.2.14 DATT MEDIPRODUCTS PRIVATE LIMITED 239 11.2.15 KORAZON MEDICAL DEVICES PRIVATE LIMITED 240 11.2.16 TRIAGE MEDITECH PVT. LTD. 241 12 APPENDIX 242 12.1 DISCUSSION GUIDE 242 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 245 12.3 CUSTOMIZATION OPTIONS 247 12.4 RELATED REPORTS 247 12.5 AUTHOR DETAILS 248
圖表清單 List of Tables & Figures
TABLE 1 NEGATIVE PRESSURE WOUND THERAPY MARKET: INCLUSIONS AND EXCLUSIONS 28 TABLE 2 NEGATIVE PRESSURE WOUND THERAPY MARKET: RISK ASSESSMENT 41 TABLE 3 POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023 50 TABLE 4 ROAD ACCIDENT DEMOGRAPHIC, 2022 51 TABLE 5 CHINA: STATES ON DISCHARGE OF PATIENTS WITH TYPE 2 DFU IN DIFFERENT AGE GROUPS, JANUARY 2017–DECEMBER 2023 52 TABLE 6 RISKS ASSOCIATED WITH NEGATIVE PRESSURE WOUND THERAPY DEVICES 55 TABLE 7 STRATEGIC DEVELOPMENTS IN ASIA PACIFIC, 2023–2024 55 TABLE 8 AVERAGE SELLING PRICING TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, 2023–2025 58 TABLE 9 AVERAGE SELLING PRICE TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, BY KEY PLAYER, 2023–2025 58 TABLE 10 AVERAGE SELLING PRICE TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, BY REGION, 2023–2025 59 TABLE 11 NEGATIVE PRESSURE WOUND THERAPY MARKET: ROLE OF COMPANIES IN ECOSYSTEM 63 TABLE 12 NEGATIVE PRESSURE WOUND THERAPY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024 66 TABLE 13 IMPORT DATA (HS CODE 901890), BY COUNTRY, 2020–2024 (USD MILLION) 67 TABLE 14 EXPORT DATA (HS CODE 901890), BY COUNTRY, 2020–2024 (USD MILLION) 67 TABLE 15 NEGATIVE PRESSURE WOUND THERAPY MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 68 TABLE 16 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN 73 TABLE 17 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 18 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75 TABLE 19 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75 TABLE 20 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 21 REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 22 NEGATIVE PRESSURE WOUND THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS 77 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS (%) 79 TABLE 24 KEY BUYING CRITERIA FOR NEGATIVE PRESSURE WOUND THERAPY PRODUCTS 80 TABLE 25 US ADJUSTED RECIPROCAL TARIFF RATES 83 TABLE 26 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 87 TABLE 27 KEY COMPANIES OFFERING CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES 88 TABLE 28 CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 88 TABLE 29 NORTH AMERICA: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 88 TABLE 30 EUROPE: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 89 TABLE 31 ASIA PACIFIC: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 89 TABLE 32 LATIN AMERICA: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 90 TABLE 33 KEY COMPANIES OFFERING SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES 91 TABLE 34 SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 91 TABLE 35 NORTH AMERICA: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 91 TABLE 36 EUROPE: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92 TABLE 37 ASIA PACIFIC: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92 TABLE 38 LATIN AMERICA: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 93 TABLE 39 KEY COMPANIES OFFERING NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES 94 TABLE 40 NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 94 TABLE 41 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 94 TABLE 42 EUROPE: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 43 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 44 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 45 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 98 TABLE 46 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY REGION, 2023–2030 (USD MILLION) 99 TABLE 47 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 48 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 49 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 50 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 51 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY REGION, 2023–2030 (USD MILLION) 102 TABLE 52 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 53 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 54 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 55 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 56 PREVALENCE OF DIABETES, 2024 104 TABLE 57 NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (THOUSANDS) 105 TABLE 58 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY REGION, 2023–2030 (USD MILLION) 105 TABLE 59 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 60 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 61 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 62 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 63 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY REGION, 2023–2030 (USD MILLION) 108 TABLE 64 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 65 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 66 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 67 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 68 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 69 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 70 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 71 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 72 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 73 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 115 TABLE 74 HOSPITALS PER CAPITA, BY COUNTRY, 2025 116 TABLE 75 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 76 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 77 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 78 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 79 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 80 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 81 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 82 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 83 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 84 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 85 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 86 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 87 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 88 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 89 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 90 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 91 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 126 TABLE 92 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 93 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 128 TABLE 94 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 128 TABLE 95 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 129 TABLE 96 US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 130 TABLE 97 US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 130 TABLE 98 US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 131 TABLE 99 CANADA: ESTIMATED PREVALENCE OF DIABETES, 2023–2024 131 TABLE 100 CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 132 TABLE 101 CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 132 TABLE 102 CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 133 TABLE 103 EUROPE: KEY MACROECONOMIC INDICATORS 134 TABLE 104 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 105 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 135 TABLE 106 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 136 TABLE 107 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 136 TABLE 108 UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 137 TABLE 109 UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 137 TABLE 110 UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 138 TABLE 111 GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 139 TABLE 112 GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 139 TABLE 113 GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 139 TABLE 114 FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 140 TABLE 115 FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 141 TABLE 116 FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 141 TABLE 117 ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 142 TABLE 118 ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 142 TABLE 119 ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 143 TABLE 120 SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 144 TABLE 121 SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 144 TABLE 122 SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 144 TABLE 123 RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 145 TABLE 124 RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 146 TABLE 125 RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 146 TABLE 126 REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 147 TABLE 127 REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 148 TABLE 128 REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 148 TABLE 129 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 149 TABLE 130 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 131 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 151 TABLE 132 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 152 TABLE 133 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 152 TABLE 134 CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 153 TABLE 135 CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 154 TABLE 136 CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 154 TABLE 137 JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 155 TABLE 138 JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 155 TABLE 139 JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 156 TABLE 140 INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 157 TABLE 141 INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 157 TABLE 142 INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 157 TABLE 143 AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 158 TABLE 144 AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 159 TABLE 145 AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 159 TABLE 146 SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 160 TABLE 147 SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 160 TABLE 148 SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 149 SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 161 TABLE 150 SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 161 TABLE 151 SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 162 TABLE 152 REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 163 TABLE 153 REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 163 TABLE 154 REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 155 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 164 TABLE 156 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 157 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 165 TABLE 158 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 165 TABLE 159 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 166 TABLE 160 BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 167 TABLE 161 BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 167 TABLE 162 BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 167 TABLE 163 MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 168 TABLE 164 MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 169 TABLE 165 MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 169 TABLE 166 REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 170 TABLE 167 REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 170 TABLE 168 REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 170 TABLE 169 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 171 TABLE 170 MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 172 TABLE 171 MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 172 TABLE 172 MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION) 172 TABLE 173 NEGATIVE PRESSURE WOUND THERAPY MARKET: OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, JANUARY 2022–MARCH 2025 174 TABLE 174 NEGATIVE PRESSURE WOUND THERAPY MARKET: DEGREE OF COMPETITION 177 TABLE 175 NEGATIVE PRESSURE WOUND THERAPY MARKET: REGION FOOTPRINT 181 TABLE 176 NEGATIVE PRESSURE WOUND THERAPY MARKET: PRODUCT TYPE FOOTPRINT 182 TABLE 177 NEGATIVE PRESSURE WOUND THERAPY MARKET: WOUND TYPE FOOTPRINT 183 TABLE 178 NEGATIVE PRESSURE WOUND THERAPY MARKET: END-USER FOOTPRINT 184 TABLE 179 NEGATIVE PRESSURE WOUND THERAPY MARKET: DETAILED LIST OF KEY STARTUPS/SMES 186 TABLE 180 NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 187 TABLE 181 NEGATIVE PRESSURE WOUND THERAPY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025 190 TABLE 182 NEGATIVE PRESSURE WOUND THERAPY MARKET: DEALS, JANUARY 2022–MARCH 2025 190 TABLE 183 NEGATIVE PRESSURE WOUND THERAPY MARKET: EXPANSIONS, JANUARY 2022–MARCH 2025 192 TABLE 184 NEGATIVE PRESSURE WOUND THERAPY MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 193 TABLE 185 SOLVENTUM: COMPANY OVERVIEW 194 TABLE 186 SOLVENTUM: PRODUCTS OFFERED 195 TABLE 187 SOLVENTUM: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025 196 TABLE 188 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 196 TABLE 189 SMITH+NEPHEW: COMPANY OVERVIEW 198 TABLE 190 SMITH+NEPHEW: PRODUCTS OFFERED 199 TABLE 191 SMITH+NEPHEW: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025 200 TABLE 192 SMITH+NEPHEW: DEALS, JANUARY 2022–MARCH 2025 200 TABLE 193 SMITH+NEPHEW: EXPANSIONS, JANUARY 2022–MARCH 2025 201 TABLE 194 CARDINAL HEALTH: COMPANY OVERVIEW 203 TABLE 195 CARDINAL HEALTH: PRODUCTS OFFERED 204 TABLE 196 CARDINAL HEALTH: DEALS, JANUARY 2022–MARCH 2025 205 TABLE 197 CARDINAL HEALTH: EXPANSIONS, JANUARY 2022–MARCH 2025 206 TABLE 198 MÖLNLYCKE AB: COMPANY OVERVIEW 208 TABLE 199 MÖLNLYCKE AB: PRODUCTS OFFERED 209 TABLE 200 MÖLNLYCKE AB: DEALS, JANUARY 2022–MARCH 2025 210 TABLE 201 CONVATEC GROUP PLC: COMPANY OVERVIEW 212 TABLE 202 CONVATEC GROUP PLC: PRODUCTS OFFERED 213 TABLE 203 CONVATEC GROUP PLC: DEALS, JANUARY 2022–MARCH 2025 214 TABLE 204 PAUL HARTMANN AG: COMPANY OVERVIEW 215 TABLE 205 PAUL HARTMANN AG: PRODUCTS OFFERED 216 TABLE 206 PAUL HARTMANN AG: DEALS, JANUARY 2022–MARCH 2025 217 TABLE 207 AVERY DENNISON CORPORATION: COMPANY OVERVIEW 218 TABLE 208 AVERY DENNISON CORPORATION: PRODUCTS OFFERED 219 TABLE 209 AVERY DENNISON CORPORATION: DEALS, JANUARY 2022–MARCH 2025 220 TABLE 210 AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2022–MARCH 2025 220 TABLE 211 BENQ MATERIALS CORPORATION: COMPANY OVERVIEW 221 TABLE 212 BENQ MATERIALS CORPORATION: PRODUCTS OFFERED 222 TABLE 213 BENQ MATERIALS CORPORATION: DEALS, JANUARY 2022–MARCH 2025 223 TABLE 214 BENQ MATERIALS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 223 TABLE 215 ADVANCED OXYGEN THERAPY INC.: COMPANY OVERVIEW 224 TABLE 216 ADVANCED OXYGEN THERAPY INC.: PRODUCTS OFFERED 225 TABLE 217 ADVANCED OXYGEN THERAPY INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025 225 TABLE 218 DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW 226 TABLE 219 CARILEX MEDICAL: COMPANY OVERVIEW 227 TABLE 220 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW 228 TABLE 221 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW 229 TABLE 222 MEDAXIS LLC: COMPANY OVERVIEW 230 TABLE 223 GENADYNE BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW 231 TABLE 224 DIRECT HEALTHCARE GROUP: COMPANY OVERVIEW 232 TABLE 225 ALLEVA MEDICAL: COMPANY OVERVIEW 233 TABLE 226 CORK MEDICAL, LLC: COMPANY OVERVIEW 234 TABLE 227 PENSAR MEDICAL: COMPANY OVERVIEW 235 TABLE 228 HAROMED: COMPANY OVERVIEW 236 TABLE 229 GUANGZHOU RAINHOME PHARM & TECH CO., LTD.: COMPANY OVERVIEW 237 TABLE 230 GUARD MEDICAL: COMPANY OVERVIEW 238 TABLE 231 DATT MEDIPRODUCTS PRIVATE LIMITED: COMPANY OVERVIEW 239 TABLE 232 KORAZON MEDICAL DEVICES PRIVATE LIMITED: COMPANY OVERVIEW 240 TABLE 233 TRIAGE MEDITECH PVT. LTD.: COMPANY OVERVIEW 241 FIGURE 1 NEGATIVE PRESSURE WOUND THERAPY MARKET SEGMENTATION AND REGIONAL SCOPE 27 FIGURE 2 NEGATIVE PRESSURE WOUND THERAPY MARKET: RESEARCH DESIGN 31 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 35 FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 36 FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 37 FIGURE 6 NEGATIVE PRESSURE WOUND THERAPY MARKET: TOP-DOWN APPROACH 38 FIGURE 7 DATA TRIANGULATION METHODOLOGY 39 FIGURE 8 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION) 42 FIGURE 9 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2025 VS. 2030 (USD MILLION) 43 FIGURE 10 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 43 FIGURE 11 GEOGRAPHICAL SNAPSHOT OF NEGATIVE PRESSURE WOUND THERAPY MARKET, 2025–2030 44 FIGURE 12 INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET 46 FIGURE 13 HOSPITALS SEGMENT AND CHINA LED ASIA PACIFIC MARKET IN 2024 47 FIGURE 14 CHINA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030 48 FIGURE 15 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 48 FIGURE 16 NEGATIVE PRESSURE WOUND THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49 FIGURE 17 NEGATIVE PRESSURE WOUND THERAPY MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 57 FIGURE 18 NEGATIVE PRESSURE WOUND THERAPY MARKET: VALUE CHAIN ANALYSIS 60 FIGURE 19 NEGATIVE PRESSURE WOUND THERAPY MARKET: SUPPLY CHAIN ANALYSIS 61 FIGURE 20 NEGATIVE PRESSURE WOUND THERAPY MARKET: ECOSYSTEM ANALYSIS 62 FIGURE 21 NEGATIVE PRESSURE WOUND THERAPY MARKET: INVESTMENT AND FUNDING SCENARIO, 2019–2025 63 FIGURE 22 NEGATIVE PRESSURE WOUND THERAPY MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024 65 FIGURE 23 NEGATIVE PRESSURE WOUND THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS 77 FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS 79 FIGURE 25 KEY BUYING CRITERIA FOR NEGATIVE PRESSURE WOUND THERAPY PRODUCTS 80 FIGURE 26 AI USE CASES 81 FIGURE 27 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET SNAPSHOT 127 FIGURE 28 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET SNAPSHOT 150 FIGURE 29 NEGATIVE PRESSURE WOUND THERAPY MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 175 FIGURE 30 NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 176 FIGURE 31 RANKING OF KEY PLAYERS IN NEGATIVE PRESSURE WOUND THERAPY MARKET, 2024 178 FIGURE 32 NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 179 FIGURE 33 NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY FOOTPRINT 180 FIGURE 34 NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 185 FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 188 FIGURE 36 EV/EBITDA OF KEY VENDORS 188 FIGURE 37 NEGATIVE PRESSURE WOUND THERAPY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 189 FIGURE 38 SOLVENTUM: COMPANY SNAPSHOT (2024) 195 FIGURE 39 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 199 FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 204 FIGURE 41 MÖLNLYCKE AB: COMPANY SNAPSHOT (2024) 209 FIGURE 42 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024) 213 FIGURE 43 PAUL HARTMANN AG: COMPANY SNAPSHOT (2024) 216 FIGURE 44 AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024) 219 FIGURE 45 BENQ MATERIALS CORPORATION: COMPANY SNAPSHOT (2023) 222 FIGURE 46 ADVANCED OXYGEN THERAPY INC.: COMPANY SNAPSHOT (2024) 224

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們